nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—ABCB1—hematologic cancer	0.0907	1	CbGaD
Nisoldipine—CYP1A2—Anagrelide—hematologic cancer	0.0273	0.0478	CbGbCtD
Nisoldipine—ABCB1—Lenalidomide—hematologic cancer	0.0165	0.029	CbGbCtD
Nisoldipine—CYP3A7—Ifosfamide—hematologic cancer	0.0159	0.0279	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.0159	0.0279	CbGbCtD
Nisoldipine—CYP3A7—Imatinib—hematologic cancer	0.0152	0.0267	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0152	0.0267	CbGbCtD
Nisoldipine—CYP3A5—Daunorubicin—hematologic cancer	0.0149	0.0261	CbGbCtD
Nisoldipine—CYP1A2—Carmustine—hematologic cancer	0.0143	0.0251	CbGbCtD
Nisoldipine—CYP3A5—Thalidomide—hematologic cancer	0.0136	0.0238	CbGbCtD
Nisoldipine—CYP3A5—Teniposide—hematologic cancer	0.013	0.0227	CbGbCtD
Nisoldipine—CYP1A2—Methoxsalen—hematologic cancer	0.0122	0.0214	CbGbCtD
Nisoldipine—CYP3A5—Ifosfamide—hematologic cancer	0.012	0.0209	CbGbCtD
Nisoldipine—CYP1A2—Bortezomib—hematologic cancer	0.0116	0.0203	CbGbCtD
Nisoldipine—CYP3A5—Imatinib—hematologic cancer	0.0114	0.02	CbGbCtD
Nisoldipine—CYP1A2—Daunorubicin—hematologic cancer	0.0111	0.0194	CbGbCtD
Nisoldipine—CYP1A2—Alitretinoin—hematologic cancer	0.0109	0.019	CbGbCtD
Nisoldipine—CYP1A2—Thalidomide—hematologic cancer	0.0101	0.0177	CbGbCtD
Nisoldipine—CYP3A4—Bexarotene—hematologic cancer	0.00991	0.0174	CbGbCtD
Nisoldipine—ABCB1—Daunorubicin—hematologic cancer	0.0097	0.017	CbGbCtD
Nisoldipine—CYP3A7—Irinotecan—hematologic cancer	0.00951	0.0166	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00951	0.0166	CbGbCtD
Nisoldipine—ABCB1—Alitretinoin—hematologic cancer	0.0095	0.0166	CbGbCtD
Nisoldipine—CYP3A4—Busulfan—hematologic cancer	0.00922	0.0161	CbGbCtD
Nisoldipine—CYP3A4—Lomustine—hematologic cancer	0.00922	0.0161	CbGbCtD
Nisoldipine—CYP3A5—Dasatinib—hematologic cancer	0.00917	0.0161	CbGbCtD
Nisoldipine—CYP1A2—Dacarbazine—hematologic cancer	0.00869	0.0152	CbGbCtD
Nisoldipine—CYP1A2—Imatinib—hematologic cancer	0.0085	0.0149	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—hematologic cancer	0.00831	0.0146	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00831	0.0146	CbGbCtD
Nisoldipine—CYP3A4—Thiotepa—hematologic cancer	0.00821	0.0144	CbGbCtD
Nisoldipine—ABCB1—Imatinib—hematologic cancer	0.00743	0.013	CbGbCtD
Nisoldipine—CYP3A5—Irinotecan—hematologic cancer	0.00713	0.0125	CbGbCtD
Nisoldipine—CYP1A2—Dasatinib—hematologic cancer	0.00683	0.012	CbGbCtD
Nisoldipine—ABCB1—Nilotinib—hematologic cancer	0.00675	0.0118	CbGbCtD
Nisoldipine—ABCB1—Vinorelbine—hematologic cancer	0.0067	0.0117	CbGbCtD
Nisoldipine—CYP3A4—Methoxsalen—hematologic cancer	0.00639	0.0112	CbGbCtD
Nisoldipine—CYP3A7—Dexamethasone—hematologic cancer	0.00626	0.011	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00626	0.011	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—hematologic cancer	0.00623	0.0109	CbGbCtD
Nisoldipine—CYP3A4—Bortezomib—hematologic cancer	0.00608	0.0106	CbGbCtD
Nisoldipine—ABCB1—Dasatinib—hematologic cancer	0.00597	0.0105	CbGbCtD
Nisoldipine—ABCB1—Mitoxantrone—hematologic cancer	0.0059	0.0103	CbGbCtD
Nisoldipine—CYP3A4—Daunorubicin—hematologic cancer	0.00581	0.0102	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—hematologic cancer	0.00571	0.01	CbGbCtD
Nisoldipine—ABCB1—Betamethasone—hematologic cancer	0.00525	0.0092	CbGbCtD
Nisoldipine—ABCB1—Gemcitabine—hematologic cancer	0.00521	0.00912	CbGbCtD
Nisoldipine—ABCB1—Prednisolone—hematologic cancer	0.00518	0.00908	CbGbCtD
Nisoldipine—CYP3A4—Cytarabine—hematologic cancer	0.00513	0.00898	CbGbCtD
Nisoldipine—CYP3A4—Teniposide—hematologic cancer	0.00505	0.00884	CbGbCtD
Nisoldipine—ABCB1—Prednisone—hematologic cancer	0.0049	0.00857	CbGbCtD
Nisoldipine—CYP3A5—Dexamethasone—hematologic cancer	0.0047	0.00822	CbGbCtD
Nisoldipine—CYP3A4—Ifosfamide—hematologic cancer	0.00466	0.00816	CbGbCtD
Nisoldipine—ABCB1—Irinotecan—hematologic cancer	0.00464	0.00813	CbGbCtD
Nisoldipine—CYP3A4—Imatinib—hematologic cancer	0.00445	0.0078	CbGbCtD
Nisoldipine—CYP1A2—Etoposide—hematologic cancer	0.00425	0.00744	CbGbCtD
Nisoldipine—CYP3A4—Ruxolitinib—hematologic cancer	0.00419	0.00734	CbGbCtD
Nisoldipine—ABCB1—Vinblastine—hematologic cancer	0.00413	0.00723	CbGbCtD
Nisoldipine—ABCB1—Vincristine—hematologic cancer	0.00406	0.0071	CbGbCtD
Nisoldipine—CYP3A4—Nilotinib—hematologic cancer	0.00405	0.00708	CbGbCtD
Nisoldipine—CYP3A4—Vinorelbine—hematologic cancer	0.00401	0.00703	CbGbCtD
Nisoldipine—ABCB1—Cisplatin—hematologic cancer	0.00378	0.00663	CbGbCtD
Nisoldipine—ABCB1—Etoposide—hematologic cancer	0.00372	0.00651	CbGbCtD
Nisoldipine—CYP3A4—Triamcinolone—hematologic cancer	0.00367	0.00643	CbGbCtD
Nisoldipine—CYP3A4—Dasatinib—hematologic cancer	0.00358	0.00626	CbGbCtD
Nisoldipine—CYP3A4—Mitoxantrone—hematologic cancer	0.00353	0.00619	CbGbCtD
Nisoldipine—CYP3A4—Betamethasone—hematologic cancer	0.00315	0.00551	CbGbCtD
Nisoldipine—CYP3A4—Prednisolone—hematologic cancer	0.00311	0.00544	CbGbCtD
Nisoldipine—ABCB1—Dexamethasone—hematologic cancer	0.00306	0.00535	CbGbCtD
Nisoldipine—CYP3A4—Prednisone—hematologic cancer	0.00293	0.00514	CbGbCtD
Nisoldipine—CYP3A4—Irinotecan—hematologic cancer	0.00278	0.00487	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—hematologic cancer	0.00254	0.00444	CbGbCtD
Nisoldipine—CYP3A4—Vinblastine—hematologic cancer	0.00247	0.00433	CbGbCtD
Nisoldipine—ABCB1—Methotrexate—hematologic cancer	0.00246	0.0043	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—hematologic cancer	0.00243	0.00426	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—hematologic cancer	0.00223	0.0039	CbGbCtD
Nisoldipine—CYP3A4—Dexamethasone—hematologic cancer	0.00183	0.00321	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—hematologic cancer	0.00152	0.00266	CbGbCtD
Nisoldipine—CACNA2D1—bone marrow—hematologic cancer	0.000501	0.064	CbGeAlD
Nisoldipine—CACNB2—lung—hematologic cancer	0.000483	0.0618	CbGeAlD
Nisoldipine—CACNB2—testis—hematologic cancer	0.000456	0.0583	CbGeAlD
Nisoldipine—CACNA2D1—lung—hematologic cancer	0.000454	0.058	CbGeAlD
Nisoldipine—CACNA2D1—testis—hematologic cancer	0.000428	0.0547	CbGeAlD
Nisoldipine—CACNA1D—lung—hematologic cancer	0.000422	0.054	CbGeAlD
Nisoldipine—CACNA1D—testis—hematologic cancer	0.000398	0.0509	CbGeAlD
Nisoldipine—CACNA1C—lung—hematologic cancer	0.00039	0.0498	CbGeAlD
Nisoldipine—CACNA1C—testis—hematologic cancer	0.000368	0.047	CbGeAlD
Nisoldipine—CYP1A2—hematopoietic system—hematologic cancer	0.000342	0.0438	CbGeAlD
Nisoldipine—CACNB2—lymph node—hematologic cancer	0.00033	0.0422	CbGeAlD
Nisoldipine—CYP3A5—hematopoietic system—hematologic cancer	0.00033	0.0422	CbGeAlD
Nisoldipine—CACNA2D1—lymph node—hematologic cancer	0.00031	0.0397	CbGeAlD
Nisoldipine—Nifedipine—ABCC3—hematologic cancer	0.000297	0.476	CrCbGaD
Nisoldipine—CACNA1D—lymph node—hematologic cancer	0.000289	0.0369	CbGeAlD
Nisoldipine—CACNA1C—lymph node—hematologic cancer	0.000266	0.0341	CbGeAlD
Nisoldipine—CYP3A4—hematopoietic system—hematologic cancer	0.000248	0.0317	CbGeAlD
Nisoldipine—CYP1A2—blood—hematologic cancer	0.000227	0.029	CbGeAlD
Nisoldipine—CYP3A5—blood—hematologic cancer	0.000219	0.028	CbGeAlD
Nisoldipine—CYP1A2—lung—hematologic cancer	0.000199	0.0254	CbGeAlD
Nisoldipine—CYP3A5—lung—hematologic cancer	0.000192	0.0245	CbGeAlD
Nisoldipine—ABCB1—hematopoietic system—hematologic cancer	0.000175	0.0224	CbGeAlD
Nisoldipine—CYP3A4—blood—hematologic cancer	0.000164	0.021	CbGeAlD
Nisoldipine—ABCB1—gonad—hematologic cancer	0.000133	0.0171	CbGeAlD
Nisoldipine—ABCB1—blood—hematologic cancer	0.000116	0.0149	CbGeAlD
Nisoldipine—ABCB1—bone marrow—hematologic cancer	0.000112	0.0144	CbGeAlD
Nisoldipine—ABCB1—lung—hematologic cancer	0.000102	0.013	CbGeAlD
Nisoldipine—ABCB1—testis—hematologic cancer	9.61e-05	0.0123	CbGeAlD
Nisoldipine—Nitrendipine—ABCB1—hematologic cancer	7.81e-05	0.125	CrCbGaD
Nisoldipine—ABCB1—lymph node—hematologic cancer	6.97e-05	0.00891	CbGeAlD
Nisoldipine—Amlodipine—ABCB1—hematologic cancer	6.73e-05	0.108	CrCbGaD
Nisoldipine—Felodipine—ABCB1—hematologic cancer	6.22e-05	0.0996	CrCbGaD
Nisoldipine—Nifedipine—ABCB1—hematologic cancer	6.01e-05	0.0963	CrCbGaD
Nisoldipine—Nicardipine—ABCB1—hematologic cancer	5.92e-05	0.0948	CrCbGaD
Nisoldipine—Anorexia—Betamethasone—hematologic cancer	3.08e-05	0.000124	CcSEcCtD
Nisoldipine—Urticaria—Prednisolone—hematologic cancer	3.08e-05	0.000124	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—hematologic cancer	3.08e-05	0.000124	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—hematologic cancer	3.06e-05	0.000123	CcSEcCtD
Nisoldipine—Rash—Vincristine—hematologic cancer	3.06e-05	0.000123	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—hematologic cancer	3.05e-05	0.000123	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—hematologic cancer	3.05e-05	0.000123	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—hematologic cancer	3.04e-05	0.000123	CcSEcCtD
Nisoldipine—Headache—Vincristine—hematologic cancer	3.04e-05	0.000122	CcSEcCtD
Nisoldipine—Loss of consciousness—Prednisone—hematologic cancer	3.03e-05	0.000122	CcSEcCtD
Nisoldipine—Hypotension—Dexamethasone—hematologic cancer	3.02e-05	0.000122	CcSEcCtD
Nisoldipine—Hypotension—Betamethasone—hematologic cancer	3.02e-05	0.000122	CcSEcCtD
Nisoldipine—Nausea—Carmustine—hematologic cancer	3.02e-05	0.000121	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—hematologic cancer	3.01e-05	0.000121	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—hematologic cancer	3e-05	0.000121	CcSEcCtD
Nisoldipine—Nausea—Alitretinoin—hematologic cancer	2.99e-05	0.00012	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—hematologic cancer	2.99e-05	0.00012	CcSEcCtD
Nisoldipine—Rash—Irinotecan—hematologic cancer	2.98e-05	0.00012	CcSEcCtD
Nisoldipine—Rash—Mitoxantrone—hematologic cancer	2.98e-05	0.00012	CcSEcCtD
Nisoldipine—Dermatitis—Irinotecan—hematologic cancer	2.97e-05	0.00012	CcSEcCtD
Nisoldipine—Dermatitis—Mitoxantrone—hematologic cancer	2.97e-05	0.00012	CcSEcCtD
Nisoldipine—Chills—Methotrexate—hematologic cancer	2.97e-05	0.00012	CcSEcCtD
Nisoldipine—Headache—Irinotecan—hematologic cancer	2.96e-05	0.000119	CcSEcCtD
Nisoldipine—Headache—Mitoxantrone—hematologic cancer	2.96e-05	0.000119	CcSEcCtD
Nisoldipine—Nausea—Ifosfamide—hematologic cancer	2.95e-05	0.000119	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.94e-05	0.000118	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.94e-05	0.000118	CcSEcCtD
Nisoldipine—Arthralgia—Prednisone—hematologic cancer	2.94e-05	0.000118	CcSEcCtD
Nisoldipine—Myalgia—Prednisone—hematologic cancer	2.94e-05	0.000118	CcSEcCtD
Nisoldipine—Feeling abnormal—Triamcinolone—hematologic cancer	2.94e-05	0.000118	CcSEcCtD
Nisoldipine—Diarrhoea—Cisplatin—hematologic cancer	2.93e-05	0.000118	CcSEcCtD
Nisoldipine—Anxiety—Prednisone—hematologic cancer	2.93e-05	0.000118	CcSEcCtD
Nisoldipine—Alopecia—Methotrexate—hematologic cancer	2.93e-05	0.000118	CcSEcCtD
Nisoldipine—Insomnia—Dexamethasone—hematologic cancer	2.92e-05	0.000118	CcSEcCtD
Nisoldipine—Insomnia—Betamethasone—hematologic cancer	2.92e-05	0.000118	CcSEcCtD
Nisoldipine—Paraesthesia—Betamethasone—hematologic cancer	2.9e-05	0.000117	CcSEcCtD
Nisoldipine—Paraesthesia—Dexamethasone—hematologic cancer	2.9e-05	0.000117	CcSEcCtD
Nisoldipine—Discomfort—Prednisone—hematologic cancer	2.9e-05	0.000117	CcSEcCtD
Nisoldipine—Rash—Gemcitabine—hematologic cancer	2.9e-05	0.000117	CcSEcCtD
Nisoldipine—Dermatitis—Gemcitabine—hematologic cancer	2.9e-05	0.000117	CcSEcCtD
Nisoldipine—Hypersensitivity—Etoposide—hematologic cancer	2.89e-05	0.000116	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—hematologic cancer	2.89e-05	0.000116	CcSEcCtD
Nisoldipine—Headache—Gemcitabine—hematologic cancer	2.88e-05	0.000116	CcSEcCtD
Nisoldipine—Nausea—Vincristine—hematologic cancer	2.88e-05	0.000116	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—hematologic cancer	2.87e-05	0.000116	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisolone—hematologic cancer	2.85e-05	0.000115	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.85e-05	0.000115	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—hematologic cancer	2.85e-05	0.000114	CcSEcCtD
Nisoldipine—Dyspepsia—Betamethasone—hematologic cancer	2.84e-05	0.000114	CcSEcCtD
Nisoldipine—Dyspepsia—Dexamethasone—hematologic cancer	2.84e-05	0.000114	CcSEcCtD
Nisoldipine—Urticaria—Triamcinolone—hematologic cancer	2.83e-05	0.000114	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—hematologic cancer	2.82e-05	0.000114	CcSEcCtD
Nisoldipine—Dysgeusia—Methotrexate—hematologic cancer	2.82e-05	0.000114	CcSEcCtD
Nisoldipine—Body temperature increased—Triamcinolone—hematologic cancer	2.82e-05	0.000113	CcSEcCtD
Nisoldipine—Oedema—Prednisone—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Nisoldipine—Decreased appetite—Dexamethasone—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Nisoldipine—Decreased appetite—Betamethasone—hematologic cancer	2.81e-05	0.000113	CcSEcCtD
Nisoldipine—Nausea—Irinotecan—hematologic cancer	2.8e-05	0.000113	CcSEcCtD
Nisoldipine—Nausea—Mitoxantrone—hematologic cancer	2.8e-05	0.000113	CcSEcCtD
Nisoldipine—Chills—Epirubicin—hematologic cancer	2.78e-05	0.000112	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—hematologic cancer	2.78e-05	0.000112	CcSEcCtD
Nisoldipine—Shock—Prednisone—hematologic cancer	2.77e-05	0.000111	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—hematologic cancer	2.76e-05	0.000111	CcSEcCtD
Nisoldipine—Tachycardia—Prednisone—hematologic cancer	2.75e-05	0.000111	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—hematologic cancer	2.74e-05	0.00011	CcSEcCtD
Nisoldipine—Nausea—Gemcitabine—hematologic cancer	2.73e-05	0.00011	CcSEcCtD
Nisoldipine—Hyperhidrosis—Prednisone—hematologic cancer	2.72e-05	0.000109	CcSEcCtD
Nisoldipine—Rash—Cisplatin—hematologic cancer	2.7e-05	0.000109	CcSEcCtD
Nisoldipine—Dermatitis—Cisplatin—hematologic cancer	2.7e-05	0.000109	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—hematologic cancer	2.69e-05	0.000108	CcSEcCtD
Nisoldipine—Anorexia—Prednisone—hematologic cancer	2.68e-05	0.000108	CcSEcCtD
Nisoldipine—Ill-defined disorder—Methotrexate—hematologic cancer	2.67e-05	0.000108	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—hematologic cancer	2.67e-05	0.000108	CcSEcCtD
Nisoldipine—Anaemia—Methotrexate—hematologic cancer	2.66e-05	0.000107	CcSEcCtD
Nisoldipine—Feeling abnormal—Dexamethasone—hematologic cancer	2.66e-05	0.000107	CcSEcCtD
Nisoldipine—Feeling abnormal—Betamethasone—hematologic cancer	2.66e-05	0.000107	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—hematologic cancer	2.66e-05	0.000107	CcSEcCtD
Nisoldipine—Tension—Epirubicin—hematologic cancer	2.65e-05	0.000106	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—hematologic cancer	2.64e-05	0.000106	CcSEcCtD
Nisoldipine—Hypersensitivity—Triamcinolone—hematologic cancer	2.62e-05	0.000106	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—hematologic cancer	2.62e-05	0.000105	CcSEcCtD
Nisoldipine—Malaise—Methotrexate—hematologic cancer	2.6e-05	0.000105	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—hematologic cancer	2.6e-05	0.000104	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—hematologic cancer	2.59e-05	0.000104	CcSEcCtD
Nisoldipine—Vertigo—Methotrexate—hematologic cancer	2.59e-05	0.000104	CcSEcCtD
Nisoldipine—Leukopenia—Methotrexate—hematologic cancer	2.58e-05	0.000104	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—hematologic cancer	2.57e-05	0.000103	CcSEcCtD
Nisoldipine—Urticaria—Betamethasone—hematologic cancer	2.57e-05	0.000103	CcSEcCtD
Nisoldipine—Urticaria—Dexamethasone—hematologic cancer	2.57e-05	0.000103	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.56e-05	0.000103	CcSEcCtD
Nisoldipine—Dizziness—Prednisolone—hematologic cancer	2.56e-05	0.000103	CcSEcCtD
Nisoldipine—Body temperature increased—Betamethasone—hematologic cancer	2.55e-05	0.000103	CcSEcCtD
Nisoldipine—Body temperature increased—Dexamethasone—hematologic cancer	2.55e-05	0.000103	CcSEcCtD
Nisoldipine—Nausea—Cisplatin—hematologic cancer	2.55e-05	0.000102	CcSEcCtD
Nisoldipine—Insomnia—Prednisone—hematologic cancer	2.55e-05	0.000102	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—hematologic cancer	2.53e-05	0.000102	CcSEcCtD
Nisoldipine—Paraesthesia—Prednisone—hematologic cancer	2.53e-05	0.000102	CcSEcCtD
Nisoldipine—Pruritus—Triamcinolone—hematologic cancer	2.52e-05	0.000101	CcSEcCtD
Nisoldipine—Cough—Methotrexate—hematologic cancer	2.52e-05	0.000101	CcSEcCtD
Nisoldipine—Ill-defined disorder—Epirubicin—hematologic cancer	2.5e-05	0.000101	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—hematologic cancer	2.49e-05	0.0001	CcSEcCtD
Nisoldipine—Dyspepsia—Prednisone—hematologic cancer	2.48e-05	9.97e-05	CcSEcCtD
Nisoldipine—Rash—Etoposide—hematologic cancer	2.48e-05	9.96e-05	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—hematologic cancer	2.47e-05	9.95e-05	CcSEcCtD
Nisoldipine—Headache—Etoposide—hematologic cancer	2.46e-05	9.9e-05	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—hematologic cancer	2.46e-05	9.89e-05	CcSEcCtD
Nisoldipine—Chest pain—Methotrexate—hematologic cancer	2.45e-05	9.87e-05	CcSEcCtD
Nisoldipine—Arthralgia—Methotrexate—hematologic cancer	2.45e-05	9.87e-05	CcSEcCtD
Nisoldipine—Myalgia—Methotrexate—hematologic cancer	2.45e-05	9.87e-05	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—hematologic cancer	2.45e-05	9.85e-05	CcSEcCtD
Nisoldipine—Decreased appetite—Prednisone—hematologic cancer	2.45e-05	9.84e-05	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—hematologic cancer	2.44e-05	9.83e-05	CcSEcCtD
Nisoldipine—Rash—Prednisolone—hematologic cancer	2.44e-05	9.83e-05	CcSEcCtD
Nisoldipine—Dermatitis—Prednisolone—hematologic cancer	2.44e-05	9.82e-05	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—hematologic cancer	2.43e-05	9.79e-05	CcSEcCtD
Nisoldipine—Headache—Prednisolone—hematologic cancer	2.43e-05	9.76e-05	CcSEcCtD
Nisoldipine—Discomfort—Methotrexate—hematologic cancer	2.42e-05	9.75e-05	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—hematologic cancer	2.42e-05	9.75e-05	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—hematologic cancer	2.42e-05	9.75e-05	CcSEcCtD
Nisoldipine—Syncope—Epirubicin—hematologic cancer	2.42e-05	9.73e-05	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—hematologic cancer	2.41e-05	9.71e-05	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—hematologic cancer	2.4e-05	9.65e-05	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—hematologic cancer	2.38e-05	9.59e-05	CcSEcCtD
Nisoldipine—Confusional state—Methotrexate—hematologic cancer	2.37e-05	9.54e-05	CcSEcCtD
Nisoldipine—Loss of consciousness—Epirubicin—hematologic cancer	2.37e-05	9.54e-05	CcSEcCtD
Nisoldipine—Dizziness—Triamcinolone—hematologic cancer	2.36e-05	9.48e-05	CcSEcCtD
Nisoldipine—Cough—Epirubicin—hematologic cancer	2.35e-05	9.47e-05	CcSEcCtD
Nisoldipine—Nausea—Etoposide—hematologic cancer	2.33e-05	9.39e-05	CcSEcCtD
Nisoldipine—Feeling abnormal—Prednisone—hematologic cancer	2.32e-05	9.33e-05	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.32e-05	9.32e-05	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—hematologic cancer	2.31e-05	9.28e-05	CcSEcCtD
Nisoldipine—Nausea—Prednisolone—hematologic cancer	2.3e-05	9.26e-05	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—hematologic cancer	2.3e-05	9.24e-05	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—hematologic cancer	2.3e-05	9.24e-05	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—hematologic cancer	2.3e-05	9.24e-05	CcSEcCtD
Nisoldipine—Anxiety—Epirubicin—hematologic cancer	2.29e-05	9.21e-05	CcSEcCtD
Nisoldipine—Pruritus—Betamethasone—hematologic cancer	2.29e-05	9.2e-05	CcSEcCtD
Nisoldipine—Pruritus—Dexamethasone—hematologic cancer	2.29e-05	9.2e-05	CcSEcCtD
Nisoldipine—Hyperhidrosis—Methotrexate—hematologic cancer	2.27e-05	9.15e-05	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—hematologic cancer	2.27e-05	9.13e-05	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—hematologic cancer	2.25e-05	9.06e-05	CcSEcCtD
Nisoldipine—Rash—Triamcinolone—hematologic cancer	2.25e-05	9.04e-05	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—hematologic cancer	2.25e-05	9.04e-05	CcSEcCtD
Nisoldipine—Dermatitis—Triamcinolone—hematologic cancer	2.24e-05	9.03e-05	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—hematologic cancer	2.24e-05	9.02e-05	CcSEcCtD
Nisoldipine—Anorexia—Methotrexate—hematologic cancer	2.24e-05	9.02e-05	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—hematologic cancer	2.24e-05	9e-05	CcSEcCtD
Nisoldipine—Urticaria—Prednisone—hematologic cancer	2.24e-05	9e-05	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—hematologic cancer	2.23e-05	8.99e-05	CcSEcCtD
Nisoldipine—Headache—Triamcinolone—hematologic cancer	2.23e-05	8.98e-05	CcSEcCtD
Nisoldipine—Body temperature increased—Prednisone—hematologic cancer	2.22e-05	8.95e-05	CcSEcCtD
Nisoldipine—Confusional state—Epirubicin—hematologic cancer	2.22e-05	8.93e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Betamethasone—hematologic cancer	2.21e-05	8.9e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Dexamethasone—hematologic cancer	2.21e-05	8.9e-05	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—hematologic cancer	2.21e-05	8.87e-05	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—hematologic cancer	2.2e-05	8.86e-05	CcSEcCtD
Nisoldipine—Hypotension—Methotrexate—hematologic cancer	2.2e-05	8.84e-05	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—hematologic cancer	2.19e-05	8.83e-05	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—hematologic cancer	2.18e-05	8.76e-05	CcSEcCtD
Nisoldipine—Shock—Epirubicin—hematologic cancer	2.17e-05	8.71e-05	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—hematologic cancer	2.15e-05	8.64e-05	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.14e-05	8.62e-05	CcSEcCtD
Nisoldipine—Dizziness—Betamethasone—hematologic cancer	2.14e-05	8.6e-05	CcSEcCtD
Nisoldipine—Dizziness—Dexamethasone—hematologic cancer	2.14e-05	8.6e-05	CcSEcCtD
Nisoldipine—Hyperhidrosis—Epirubicin—hematologic cancer	2.13e-05	8.56e-05	CcSEcCtD
Nisoldipine—Insomnia—Methotrexate—hematologic cancer	2.13e-05	8.56e-05	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—hematologic cancer	2.12e-05	8.55e-05	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—hematologic cancer	2.12e-05	8.55e-05	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—hematologic cancer	2.12e-05	8.55e-05	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—hematologic cancer	2.12e-05	8.52e-05	CcSEcCtD
Nisoldipine—Nausea—Triamcinolone—hematologic cancer	2.12e-05	8.51e-05	CcSEcCtD
Nisoldipine—Paraesthesia—Methotrexate—hematologic cancer	2.11e-05	8.5e-05	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—hematologic cancer	2.1e-05	8.45e-05	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—hematologic cancer	2.1e-05	8.44e-05	CcSEcCtD
Nisoldipine—Dyspnoea—Methotrexate—hematologic cancer	2.1e-05	8.44e-05	CcSEcCtD
Nisoldipine—Somnolence—Methotrexate—hematologic cancer	2.09e-05	8.41e-05	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—hematologic cancer	2.08e-05	8.36e-05	CcSEcCtD
Nisoldipine—Hypersensitivity—Prednisone—hematologic cancer	2.07e-05	8.34e-05	CcSEcCtD
Nisoldipine—Dyspepsia—Methotrexate—hematologic cancer	2.07e-05	8.33e-05	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—hematologic cancer	2.06e-05	8.28e-05	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—hematologic cancer	2.05e-05	8.26e-05	CcSEcCtD
Nisoldipine—Decreased appetite—Methotrexate—hematologic cancer	2.04e-05	8.23e-05	CcSEcCtD
Nisoldipine—Rash—Dexamethasone—hematologic cancer	2.04e-05	8.2e-05	CcSEcCtD
Nisoldipine—Rash—Betamethasone—hematologic cancer	2.04e-05	8.2e-05	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—hematologic cancer	2.04e-05	8.2e-05	CcSEcCtD
Nisoldipine—Dermatitis—Betamethasone—hematologic cancer	2.04e-05	8.19e-05	CcSEcCtD
Nisoldipine—Dermatitis—Dexamethasone—hematologic cancer	2.04e-05	8.19e-05	CcSEcCtD
Nisoldipine—Headache—Betamethasone—hematologic cancer	2.02e-05	8.15e-05	CcSEcCtD
Nisoldipine—Headache—Dexamethasone—hematologic cancer	2.02e-05	8.15e-05	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.01e-05	8.07e-05	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—hematologic cancer	2e-05	8.06e-05	CcSEcCtD
Nisoldipine—Pruritus—Prednisone—hematologic cancer	1.99e-05	8.01e-05	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—hematologic cancer	1.99e-05	8.01e-05	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—hematologic cancer	1.99e-05	8e-05	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—hematologic cancer	1.98e-05	7.95e-05	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.97e-05	7.92e-05	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—hematologic cancer	1.96e-05	7.9e-05	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—hematologic cancer	1.96e-05	7.87e-05	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—hematologic cancer	1.94e-05	7.81e-05	CcSEcCtD
Nisoldipine—Feeling abnormal—Methotrexate—hematologic cancer	1.94e-05	7.8e-05	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—hematologic cancer	1.94e-05	7.8e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Prednisone—hematologic cancer	1.93e-05	7.75e-05	CcSEcCtD
Nisoldipine—Nausea—Dexamethasone—hematologic cancer	1.92e-05	7.72e-05	CcSEcCtD
Nisoldipine—Nausea—Betamethasone—hematologic cancer	1.92e-05	7.72e-05	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—hematologic cancer	1.91e-05	7.7e-05	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—hematologic cancer	1.9e-05	7.66e-05	CcSEcCtD
Nisoldipine—Urticaria—Methotrexate—hematologic cancer	1.87e-05	7.52e-05	CcSEcCtD
Nisoldipine—Dizziness—Prednisone—hematologic cancer	1.86e-05	7.49e-05	CcSEcCtD
Nisoldipine—Body temperature increased—Methotrexate—hematologic cancer	1.86e-05	7.48e-05	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.86e-05	7.47e-05	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—hematologic cancer	1.84e-05	7.41e-05	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—hematologic cancer	1.83e-05	7.36e-05	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—hematologic cancer	1.82e-05	7.31e-05	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—hematologic cancer	1.81e-05	7.3e-05	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—hematologic cancer	1.81e-05	7.29e-05	CcSEcCtD
Nisoldipine—Dyspepsia—Doxorubicin—hematologic cancer	1.79e-05	7.21e-05	CcSEcCtD
Nisoldipine—Rash—Prednisone—hematologic cancer	1.77e-05	7.14e-05	CcSEcCtD
Nisoldipine—Dermatitis—Prednisone—hematologic cancer	1.77e-05	7.13e-05	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—hematologic cancer	1.77e-05	7.12e-05	CcSEcCtD
Nisoldipine—Headache—Prednisone—hematologic cancer	1.76e-05	7.09e-05	CcSEcCtD
Nisoldipine—Urticaria—Epirubicin—hematologic cancer	1.75e-05	7.04e-05	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—hematologic cancer	1.74e-05	7e-05	CcSEcCtD
Nisoldipine—Hypersensitivity—Methotrexate—hematologic cancer	1.73e-05	6.97e-05	CcSEcCtD
Nisoldipine—Feeling abnormal—Doxorubicin—hematologic cancer	1.68e-05	6.75e-05	CcSEcCtD
Nisoldipine—Nausea—Prednisone—hematologic cancer	1.67e-05	6.73e-05	CcSEcCtD
Nisoldipine—Pruritus—Methotrexate—hematologic cancer	1.66e-05	6.7e-05	CcSEcCtD
Nisoldipine—Hypersensitivity—Epirubicin—hematologic cancer	1.62e-05	6.53e-05	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—hematologic cancer	1.62e-05	6.51e-05	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—hematologic cancer	1.61e-05	6.48e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Methotrexate—hematologic cancer	1.61e-05	6.48e-05	CcSEcCtD
Nisoldipine—Pruritus—Epirubicin—hematologic cancer	1.56e-05	6.27e-05	CcSEcCtD
Nisoldipine—Dizziness—Methotrexate—hematologic cancer	1.56e-05	6.26e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Epirubicin—hematologic cancer	1.51e-05	6.06e-05	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—hematologic cancer	1.5e-05	6.04e-05	CcSEcCtD
Nisoldipine—Rash—Methotrexate—hematologic cancer	1.48e-05	5.97e-05	CcSEcCtD
Nisoldipine—Dermatitis—Methotrexate—hematologic cancer	1.48e-05	5.96e-05	CcSEcCtD
Nisoldipine—Headache—Methotrexate—hematologic cancer	1.47e-05	5.93e-05	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—hematologic cancer	1.46e-05	5.86e-05	CcSEcCtD
Nisoldipine—Pruritus—Doxorubicin—hematologic cancer	1.44e-05	5.8e-05	CcSEcCtD
Nisoldipine—Nausea—Methotrexate—hematologic cancer	1.4e-05	5.62e-05	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—hematologic cancer	1.39e-05	5.61e-05	CcSEcCtD
Nisoldipine—Rash—Epirubicin—hematologic cancer	1.39e-05	5.58e-05	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—hematologic cancer	1.39e-05	5.58e-05	CcSEcCtD
Nisoldipine—Headache—Epirubicin—hematologic cancer	1.38e-05	5.55e-05	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—hematologic cancer	1.35e-05	5.42e-05	CcSEcCtD
Nisoldipine—Nausea—Epirubicin—hematologic cancer	1.31e-05	5.26e-05	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—hematologic cancer	1.28e-05	5.17e-05	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—hematologic cancer	1.28e-05	5.16e-05	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—hematologic cancer	1.28e-05	5.13e-05	CcSEcCtD
Nisoldipine—Nausea—Doxorubicin—hematologic cancer	1.21e-05	4.87e-05	CcSEcCtD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	8.69e-06	0.000107	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AGRN—hematologic cancer	8.66e-06	0.000107	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GBA—hematologic cancer	8.65e-06	0.000106	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SLC35B2—hematologic cancer	8.65e-06	0.000106	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—CREBBP—hematologic cancer	8.54e-06	0.000105	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SLC22A1—hematologic cancer	8.46e-06	0.000104	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CRABP1—hematologic cancer	8.46e-06	0.000104	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	8.45e-06	0.000104	CbGpPWpGaD
Nisoldipine—CACNA1D—Developmental Biology—AKT1—hematologic cancer	8.37e-06	0.000103	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—HRAS—hematologic cancer	8.33e-06	0.000102	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	8.28e-06	0.000102	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ASNS—hematologic cancer	8.28e-06	0.000102	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—DCK—hematologic cancer	8.28e-06	0.000102	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CD44—hematologic cancer	8.25e-06	0.000101	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NQO1—hematologic cancer	8.25e-06	0.000101	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ALOX5—hematologic cancer	8.24e-06	0.000101	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	8.23e-06	0.000101	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—IDH2—hematologic cancer	8.21e-06	0.000101	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HMMR—hematologic cancer	8.21e-06	0.000101	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3CD—hematologic cancer	8.1e-06	9.96e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—CREBBP—hematologic cancer	8.09e-06	9.95e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—ALB—hematologic cancer	7.99e-06	9.83e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NUP98—hematologic cancer	7.98e-06	9.82e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—IL6—hematologic cancer	7.97e-06	9.81e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MTAP—hematologic cancer	7.91e-06	9.73e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HDC—hematologic cancer	7.85e-06	9.66e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CYCS—hematologic cancer	7.8e-06	9.6e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	7.79e-06	9.58e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—HSP90AA1—hematologic cancer	7.75e-06	9.54e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ADCY7—hematologic cancer	7.75e-06	9.54e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NCOA3—hematologic cancer	7.75e-06	9.54e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ARNTL—hematologic cancer	7.72e-06	9.5e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NUP214—hematologic cancer	7.7e-06	9.47e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3CD—hematologic cancer	7.67e-06	9.43e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CG—hematologic cancer	7.66e-06	9.43e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3R1—hematologic cancer	7.65e-06	9.41e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	7.57e-06	9.32e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—ALB—hematologic cancer	7.57e-06	9.31e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	7.56e-06	9.3e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ABCG2—hematologic cancer	7.54e-06	9.28e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—MTR—hematologic cancer	7.54e-06	9.28e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ACP5—hematologic cancer	7.51e-06	9.24e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CA9—hematologic cancer	7.51e-06	9.24e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NCOR2—hematologic cancer	7.41e-06	9.12e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ENO2—hematologic cancer	7.39e-06	9.1e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Developmental Biology—AKT1—hematologic cancer	7.35e-06	9.05e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3R1—hematologic cancer	7.24e-06	8.91e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CDA—hematologic cancer	7.18e-06	8.83e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTT1—hematologic cancer	7.17e-06	8.82e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—CREBBP—hematologic cancer	7.11e-06	8.74e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—IDH1—hematologic cancer	7.06e-06	8.68e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3CB—hematologic cancer	7.06e-06	8.68e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	7.06e-06	8.68e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—FHL2—hematologic cancer	7.05e-06	8.67e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—SDC1—hematologic cancer	7.01e-06	8.62e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	7e-06	8.61e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ABCC3—hematologic cancer	6.98e-06	8.59e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTO1—hematologic cancer	6.98e-06	8.59e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—TXN—hematologic cancer	6.98e-06	8.59e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AGRN—hematologic cancer	6.91e-06	8.5e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PC—hematologic cancer	6.91e-06	8.5e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTP1—hematologic cancer	6.88e-06	8.46e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SPHK1—hematologic cancer	6.83e-06	8.4e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CD—hematologic cancer	6.74e-06	8.29e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3CB—hematologic cancer	6.68e-06	8.22e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GBA—hematologic cancer	6.67e-06	8.21e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.67e-06	8.21e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—ALB—hematologic cancer	6.65e-06	8.18e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—UGT1A1—hematologic cancer	6.56e-06	8.07e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HMMR—hematologic cancer	6.55e-06	8.06e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—IDH2—hematologic cancer	6.55e-06	8.06e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ABCB1—hematologic cancer	6.51e-06	8.01e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	6.43e-06	7.91e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CRABP1—hematologic cancer	6.38e-06	7.85e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SLC22A1—hematologic cancer	6.38e-06	7.85e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3R1—hematologic cancer	6.36e-06	7.83e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—GSTM1—hematologic cancer	6.32e-06	7.78e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—NCOR1—hematologic cancer	6.32e-06	7.78e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ALOX5—hematologic cancer	6.22e-06	7.65e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	6.22e-06	7.65e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.18e-06	7.6e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.16e-06	7.58e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MTAP—hematologic cancer	6.1e-06	7.51e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PTEN—hematologic cancer	6.1e-06	7.5e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NUP98—hematologic cancer	6.03e-06	7.41e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ACP5—hematologic cancer	5.99e-06	7.37e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CA9—hematologic cancer	5.99e-06	7.37e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CD44—hematologic cancer	5.96e-06	7.33e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NQO1—hematologic cancer	5.96e-06	7.33e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.92e-06	7.28e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CB—hematologic cancer	5.87e-06	7.22e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ADCY7—hematologic cancer	5.85e-06	7.2e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NCOA3—hematologic cancer	5.85e-06	7.2e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—EP300—hematologic cancer	5.82e-06	7.16e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NUP214—hematologic cancer	5.81e-06	7.15e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PTEN—hematologic cancer	5.78e-06	7.11e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ABCG2—hematologic cancer	5.69e-06	7e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—MTR—hematologic cancer	5.69e-06	7e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CYCS—hematologic cancer	5.64e-06	6.94e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—IDH1—hematologic cancer	5.64e-06	6.93e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	5.6e-06	6.89e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—MTHFR—hematologic cancer	5.59e-06	6.87e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ENO2—hematologic cancer	5.58e-06	6.87e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.57e-06	6.86e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.57e-06	6.86e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—TXN—hematologic cancer	5.57e-06	6.86e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—EP300—hematologic cancer	5.51e-06	6.78e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.45e-06	6.71e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—FHL2—hematologic cancer	5.44e-06	6.69e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTT1—hematologic cancer	5.41e-06	6.66e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AGRN—hematologic cancer	5.34e-06	6.56e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—SDC1—hematologic cancer	5.29e-06	6.51e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	5.25e-06	6.46e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.24e-06	6.45e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.1e-06	6.27e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.1e-06	6.27e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PTEN—hematologic cancer	5.07e-06	6.24e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	5.07e-06	6.23e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HMMR—hematologic cancer	5.06e-06	6.22e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—IDH2—hematologic cancer	5.06e-06	6.22e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.97e-06	6.12e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.97e-06	6.11e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—EP300—hematologic cancer	4.84e-06	5.95e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NUP98—hematologic cancer	4.81e-06	5.92e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.76e-06	5.85e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	4.74e-06	5.84e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.71e-06	5.79e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.69e-06	5.77e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.67e-06	5.74e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.67e-06	5.74e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NUP214—hematologic cancer	4.64e-06	5.7e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CA9—hematologic cancer	4.63e-06	5.69e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.63e-06	5.69e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.59e-06	5.65e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.57e-06	5.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.57e-06	5.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.57e-06	5.62e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MTR—hematologic cancer	4.54e-06	5.59e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.54e-06	5.59e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NQO1—hematologic cancer	4.5e-06	5.53e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CD44—hematologic cancer	4.5e-06	5.53e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ENO2—hematologic cancer	4.45e-06	5.48e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—CREBBP—hematologic cancer	4.35e-06	5.35e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—IDH1—hematologic cancer	4.35e-06	5.35e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.32e-06	5.32e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—PIK3CA—hematologic cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—TXN—hematologic cancer	4.3e-06	5.29e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CYCS—hematologic cancer	4.26e-06	5.24e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.25e-06	5.23e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	4.23e-06	5.2e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—SDC1—hematologic cancer	4.22e-06	5.2e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.21e-06	5.18e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	4.13e-06	5.08e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—PIK3CA—hematologic cancer	4.07e-06	5.01e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—ALB—hematologic cancer	4.07e-06	5.01e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.04e-06	4.97e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—MTHFR—hematologic cancer	4.04e-06	4.97e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.03e-06	4.96e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.98e-06	4.9e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.93e-06	4.84e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.93e-06	4.84e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.9e-06	4.79e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.83e-06	4.72e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.81e-06	4.69e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTP1—hematologic cancer	3.75e-06	4.62e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.71e-06	4.57e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.6e-06	4.43e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.6e-06	4.43e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.6e-06	4.42e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NQO1—hematologic cancer	3.59e-06	4.42e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CD44—hematologic cancer	3.59e-06	4.42e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—PIK3CA—hematologic cancer	3.58e-06	4.4e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.58e-06	4.4e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.52e-06	4.33e-05	CbGpPWpGaD
Nisoldipine—CACNB2—Metabolism—AKT1—hematologic cancer	3.51e-06	4.32e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MTR—hematologic cancer	3.51e-06	4.31e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.51e-06	4.31e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—NCOR1—hematologic cancer	3.45e-06	4.24e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—GSTM1—hematologic cancer	3.45e-06	4.24e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.44e-06	4.23e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CYCS—hematologic cancer	3.4e-06	4.18e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	3.39e-06	4.17e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.38e-06	4.15e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.33e-06	4.1e-05	CbGpPWpGaD
Nisoldipine—CACNA1D—Metabolism—AKT1—hematologic cancer	3.33e-06	4.09e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.26e-06	4.01e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—CREBBP—hematologic cancer	3.15e-06	3.87e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PTEN—hematologic cancer	3.11e-06	3.82e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—MTHFR—hematologic cancer	3.05e-06	3.75e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.04e-06	3.74e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.99e-06	3.68e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.98e-06	3.67e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—EP300—hematologic cancer	2.96e-06	3.65e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—ALB—hematologic cancer	2.94e-06	3.62e-05	CbGpPWpGaD
Nisoldipine—CACNA1C—Metabolism—AKT1—hematologic cancer	2.92e-06	3.6e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.9e-06	3.56e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.83e-06	3.49e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.82e-06	3.46e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CD44—hematologic cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.77e-06	3.41e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.75e-06	3.39e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.75e-06	3.39e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.62e-06	3.23e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.61e-06	3.21e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.6e-06	3.2e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CG—hematologic cancer	2.56e-06	3.15e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.43e-06	2.99e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—CREBBP—hematologic cancer	2.37e-06	2.92e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.31e-06	2.84e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CD—hematologic cancer	2.25e-06	2.77e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PTEN—hematologic cancer	2.25e-06	2.76e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—ALB—hematologic cancer	2.22e-06	2.73e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	2.19e-06	2.7e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.19e-06	2.69e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.14e-06	2.64e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—EP300—hematologic cancer	2.14e-06	2.64e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.12e-06	2.61e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.12e-06	2.61e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.12e-06	2.61e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.04e-06	2.51e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.96e-06	2.41e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.89e-06	2.33e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.88e-06	2.31e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.8e-06	2.21e-05	CbGpPWpGaD
Nisoldipine—CYP3A7—Metabolism—AKT1—hematologic cancer	1.79e-06	2.2e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—ALB—hematologic cancer	1.77e-06	2.18e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.7e-06	2.09e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PTEN—hematologic cancer	1.69e-06	2.09e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—EP300—hematologic cancer	1.62e-06	1.99e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.58e-06	1.95e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.58e-06	1.94e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.57e-06	1.93e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.46e-06	1.8e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.39e-06	1.71e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—ALB—hematologic cancer	1.37e-06	1.68e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.35e-06	1.66e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.31e-06	1.61e-05	CbGpPWpGaD
Nisoldipine—CYP3A5—Metabolism—AKT1—hematologic cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—EP300—hematologic cancer	1.29e-06	1.59e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.21e-06	1.49e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.2e-06	1.47e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.04e-06	1.28e-05	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—EP300—hematologic cancer	9.96e-07	1.23e-05	CbGpPWpGaD
Nisoldipine—ABCB1—Metabolism—AKT1—hematologic cancer	9.77e-07	1.2e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.55e-07	1.17e-05	CbGpPWpGaD
Nisoldipine—CYP1A2—Metabolism—AKT1—hematologic cancer	7.8e-07	9.59e-06	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.37e-07	9.06e-06	CbGpPWpGaD
Nisoldipine—CYP3A4—Metabolism—AKT1—hematologic cancer	6.02e-07	7.4e-06	CbGpPWpGaD
